Literature DB >> 18704032

Continued early onset group B streptococcal infections in the era of intrapartum prophylaxis.

L S Pulver1, M M Hopfenbeck, P C Young, G J Stoddard, K Korgenski, J Daly, C L Byington.   

Abstract

OBJECTIVE: The objective of the study was to determine the rate of early onset group B streptococcus (EOGBS) infection in Utah and identify potential areas of failure in EOGBS prevention. STUDY
DESIGN: We queried the microbiology records of Intermountain Healthcare for infants with culture-confirmed EOGBS between 1 January 2002 and 31 May 2006 and calculated rates of EOGBS per 1000 deliveries. We reviewed the infant and maternal records of each EOGBS case to identify possible failures in EOGBS prevention. RESULT: There were 54 cases of EOGBS among the 127 205 births (0.42/1000 births). Of all, 12 were preterm. Of the 39 (93%) women prenatally screened for GBS, 31 (79%) had negative results and 7/8 (88%) women with positive prenatal GBS screens either did not receive intrapartum antibiotic prophylaxis (IAP) or received inadequate IAP. Of the 54 infants with EOGBS, 3 (6%) died.
CONCLUSION: Utah's rates of EOGBS were higher than the national average. Factors associated with EOGBS include missed screening opportunities, inadequate IAP, and false-negative maternal GBS culture.

Entities:  

Mesh:

Year:  2008        PMID: 18704032     DOI: 10.1038/jp.2008.115

Source DB:  PubMed          Journal:  J Perinatol        ISSN: 0743-8346            Impact factor:   2.521


  8 in total

1.  Assessment of intrapartum antibiotic prophylaxis for the prevention of early-onset group B Streptococcal disease.

Authors:  Feng-Ying C Lin; Leonard E Weisman; Parvin Azimi; Amy E Young; Kathleen Chang; Mikhaela Cielo; Patricia Moyer; James F Troendle; Rachel Schneerson; John B Robbins
Journal:  Pediatr Infect Dis J       Date:  2011-09       Impact factor: 2.129

2.  Preterm infants have deficient monocyte and lymphocyte cytokine responses to group B streptococcus.

Authors:  Andrew J Currie; Samantha Curtis; Tobias Strunk; Karen Riley; Khemanganee Liyanage; Susan Prescott; Dorota Doherty; Karen Simmer; Peter Richmond; David Burgner
Journal:  Infect Immun       Date:  2011-02-07       Impact factor: 3.441

3.  Incidence and outcome of group B streptococcal invasive disease in Omani infants.

Authors:  Eman Al Masroori; Wafa Bani Uraba; Hilal Al Hashami
Journal:  Int J Pediatr Adolesc Med       Date:  2019-05-29

4.  Universal versus Risk-Based Management of Unknown Group B Streptococcus Status at Term.

Authors:  Danielle M Jones; Samantha O Haikal; Megan D Whitham; David L Howard
Journal:  AJP Rep       Date:  2019-09-30

5.  Neonatal purpura fulminans manifestation in early-onset group B Streptococcal infection.

Authors:  May Albarrak; Abdulrahman Al-Matary
Journal:  Am J Case Rep       Date:  2013-08-16

6.  The essential genome of Streptococcus agalactiae.

Authors:  Thomas A Hooven; Andrew J Catomeris; Leor H Akabas; Tara M Randis; Duncan J Maskell; Sarah E Peters; Sandra Ott; Ivette Santana-Cruz; Luke J Tallon; Hervé Tettelin; Adam J Ratner
Journal:  BMC Genomics       Date:  2016-05-26       Impact factor: 3.969

7.  Intrapartum PCR assay versus antepartum culture for assessment of vaginal carriage of group B streptococci in a Danish cohort at birth.

Authors:  Mohammed Rohi Khalil; Niels Uldbjerg; Poul Bak Thorsen; Jens Kjølseth Møller
Journal:  PLoS One       Date:  2017-07-05       Impact factor: 3.240

8.  Assessment of conventional PCR and real-time PCR compared to the gold standard method for screening Streptococcus agalactiae in pregnant women.

Authors:  Michele Berger Ferreira; Fernanda de-Paris; Rodrigo Minuto Paiva; Luciana de Souza Nunes
Journal:  Braz J Infect Dis       Date:  2018-11-22       Impact factor: 3.257

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.